Black Cohosh Does Not Increase Breast Cancer RiskBlack Cohosh Does Not Increase Breast Cancer Risk
December 5, 2007
COLUMBIA, Mo.Researchers from the University of Missouri, Columbia, investigated the possible estrogenic influence of black cohosh extract (BCE) on the breast (Lawrence Erlbaum Assoc., Inc. 2007; 59(2):269-77). While some studies have suggested hormone replacement therapy may increase the risk of breast cancer and cardiovascular disease (CVD), studies on black cohosh have had mixed results.In this study, BCE was administered to postmenopausal women for 12 weeks followed by a 12-week washout. Participants taking BCE with 2.5 percent triterpenes had relief from menopausal symptoms, with reversion toward baseline after washout; in addition, the standardized BCE had no breast-specific estrogenic effects.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023